malondialdehyde has been researched along with Hypertrophy, Right Ventricular in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Cui, H; Du, GQ; Li, Y; Shen, W; Sun, P; Wang, C; Xue, JY; Zhao, P | 1 |
| Huang, Z; Li, Z; Lu, D; Ma, K; Nan, X; Su, S; Xu, S; Yang, Z; Zhang, E | 1 |
| An, N; Feng, W; Feng, Z; Guan, H; Hu, T; Hu, Y; Liu, J; Mao, Y; Mou, J; Zhang, D | 1 |
| Comunoglu, C; Macit, A; Silan, C; Uzun, O; Yavuz, O; Yavuz, T; Yildirim, HA; Yuksel, H | 1 |
| Chen, C; Dong, W; Lin, X; Lv, S; Tong, G; Wang, X; Yang, D; Yang, Y | 1 |
| Han, X; Long, Y; Zhang, X; Zhang, Y; Zhou, Z | 1 |
| Bu, HM; Guo, Z; Wang, X; Xu, Y; Yuan, F; Zhang, Y; Zhong, N; Zhou, ZN | 1 |
| Han, JJ; Jing, L; Qin, SC; Sun, XJ; Wang, Y; Wu, YP; Xia, ZL; Zhao, XM | 1 |
| Cui, B; Dai, DZ; Tang, XY; Zhang, TT | 1 |
| Arbak, P; Balbay, O; Comunoğlu, NU; Erbaş, M; Güler, S; Nihat Annakkaya, A; Silan, C; Uzun, O; Yavuz, O | 1 |
10 other study(ies) available for malondialdehyde and Hypertrophy, Right Ventricular
| Article | Year |
|---|---|
Melatonin activates the Mst1-Nrf2 signaling to alleviate cardiac hypertrophy in pulmonary arterial hypertension.
Topics: Animals; Antioxidants; Arginine Vasopressin; Cysteine; Disease Models, Animal; Familial Primary Pulmonary Hypertension; Hepatocyte Growth Factor; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Malondialdehyde; Melatonin; Monocrotaline; NF-E2-Related Factor 2; Proto-Oncogene Proteins; Pulmonary Arterial Hypertension; Rats; RNA, Small Interfering; Ventricular Remodeling | 2022 |
The Mechanism of Volatile Oil of
Topics: Angiotensin-Converting Enzyme 2; Animals; Eosine Yellowish-(YS); Glutathione; Hematoxylin; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Male; Malondialdehyde; Oils, Volatile; Oxidants; Oxygen; Rats; Rats, Sprague-Dawley; Rhodiola; Superoxide Dismutase | 2022 |
Alginate Oligosaccharide Alleviates Monocrotaline-Induced Pulmonary Hypertension via Anti-Oxidant and Anti-Inflammation Pathways in Rats.
Topics: Alginates; Animals; Anti-Inflammatory Agents; Antioxidants; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertrophy, Right Ventricular; Injections, Intraperitoneal; Male; Malondialdehyde; Monocrotaline; Pulmonary Arterial Hypertension; Random Allocation; Rats; Vascular Remodeling | 2020 |
Pyrrolidine dithiocarbamate attenuates the development of monocrotaline-induced pulmonary arterial hypertension.
Topics: Animals; Antioxidants; Disease Models, Animal; Endothelium, Vascular; Erythrocytes; Familial Primary Pulmonary Hypertension; Hematocrit; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Malondialdehyde; Monocrotaline; Pyrrolidines; Rats; Rats, Sprague-Dawley; Thiocarbamates | 2013 |
Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
Topics: Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Antioxidants; Arterial Pressure; Benzylisoquinolines; Catalase; Cell Proliferation; Cyclic GMP-Dependent Protein Kinase Type I; Disease Models, Animal; Glutathione; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Male; Malondialdehyde; Monocrotaline; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide Synthase Type II; Oxidative Stress; Pulmonary Artery; Rats, Sprague-Dawley; Signal Transduction; Superoxide Dismutase; Time Factors; Vascular Remodeling; Ventricular Remodeling | 2016 |
Hydroxysafflor yellow A improves established monocrotaline-induced pulmonary arterial hypertension in rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Chalcone; Deoxyguanosine; Gene Expression Regulation; Hemodynamics; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Inflammation; Male; Malondialdehyde; Monocrotaline; Oxidative Stress; Quinones; Rats, Wistar; RNA, Messenger; Superoxide Dismutase; Vascular Remodeling | 2016 |
Comparison of the effects of chronic intermittent hypobaric hypoxia and continuous hypobaric hypoxia on hemodynamics in rats.
Topics: Altitude; Animals; Heart; Hemodynamics; Hypertrophy, Right Ventricular; Hypoxia; Male; Malondialdehyde; Myocardium; Rats; Rats, Sprague-Dawley; Superoxide Dismutase | 2008 |
Protective effects of hydrogen-rich saline on monocrotaline-induced pulmonary hypertension in a rat model.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Anti-Inflammatory Agents; Antihypertensive Agents; Antioxidants; Biomarkers; Blood Pressure; Deoxyguanosine; Enzyme-Linked Immunosorbent Assay; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Inflammation Mediators; Interleukin-6; Male; Malondialdehyde; Monocrotaline; Rats; Rats, Sprague-Dawley; Sodium Chloride; Superoxide Dismutase; Time Factors; Tumor Necrosis Factor-alpha | 2011 |
Pharmacological efficacy of CPU 86017 on hypoxic pulmonary hypertension in rats: mediated by direct inhibition of calcium channels and antioxidant action, but indirect effects on the ET-1 pathway.
Topics: Animals; Antioxidants; Berberine; Calcium Channel Blockers; Calcium Channels, L-Type; Endothelin-1; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Male; Malondialdehyde; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Pulmonary Artery; Rats; Rats, Sprague-Dawley | 2005 |
Hypobaric-hypoxia-induced pulmonary damage in rats ameliorated by antioxidant erdosteine.
Topics: Animals; Antibodies, Monoclonal; Antioxidants; Atmosphere Exposure Chambers; Atmospheric Pressure; Endothelial Cells; Hematocrit; Hemorrhage; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Immunohistochemistry; Lung; Malondialdehyde; Pulmonary Artery; Random Allocation; Rats; Thioglycolates; Thiophenes | 2006 |